-

Eurofins MET Labs Recognized for Instrumental Support in Intuitive Machines’ IM-1 Lunar Mission

HOUSTON--(BUSINESS WIRE)--Eurofins MET Labs, part of the global network of Eurofins (Paris:ERF) laboratories and a global leader in product safety approvals and regulatory certification, has been officially recognized by Intuitive Machines for their crucial contribution to their IM-1 lunar mission. In a significant gesture of acknowledgment, Intuitive Machines has etched the Eurofins MET Labs name onto the lunar lander, symbolizing their lasting contribution to this groundbreaking mission.

The Intuitive Machines IM-1 mission, launched from Launch Complex 39A at NASA’s Kennedy Space Center in Florida at 1:05 a.m. EST, Thursday, February 15, 2024. It reached its intended orbit approximately 48 minutes later and established first communication with the lander at 1:59 a.m. EST.

The mission represents a pivotal venture within NASA’s Commercial Lunar Payload Services (CLPS) initiative. The CLPS initiative is a foundational element of NASA's broader Artemis program and aims to foster the development of commercial lunar capabilities.

Eurofins MET Labs was instrumental in this mission, leveraging its expertise to ensure the IM-1 Lander meets the stringent safety and quality standards essential for space exploration. The Eurofins MET Labs Environmental Simulation Lab in Baltimore, MD carried out the comprehensive testing and certification of the IM-1 Lander's components and systems.

Eurofins MET Labs holds accreditations from both the International Organization for Standardization (ISO) and the American Association for Laboratory Accreditation (A2LA). Their comprehensive solutions span Electromagnetic Compatibility (EMC), environmental, and safety testing and certification.

About Intuitive Machines

Intuitive Machines is a diversified space company focused on space exploration. Intuitive Machines supplies space products and services to support sustained robotic and human exploration to the Moon, Mars, and beyond. Intuitive Machines’ products and services are offered through its four business units: Lunar Access Services, Orbital Services, Lunar Data Services, and Space Products and Infrastructure. For more information, please visit intuitivemachines.com.

About Eurofins – the global leader in bio-analysis

Eurofins MET Labs is part of the global network of Eurofins laboratories.

Eurofins is Testing for Life. The Eurofins network of companies believes that it is a global leader in food, environment, pharmaceutical and cosmetic product testing and in discovery pharmacology, forensics, advanced material sciences and agroscience contract research services. It is also one of the market leaders in certain testing and laboratory services for genomics, and in the support of clinical studies, as well as in biopharma contract development and manufacturing. It also has a rapidly developing presence in highly specialised and molecular clinical diagnostic testing and in-vitro diagnostic products.

With over 61,000 staff across a network of ca. 900 laboratories in 61 countries, Eurofins offers a portfolio of over 200,000 analytical methods.

Eurofins Shares are listed on Euronext Paris Stock Exchange.

Contacts

For more information, please contact:

Fredis Benitez
Global Marketing Analytics Manager, CPT
Mobile: +1 346-739-3816
E-mail: fredis.benitez@cpt.eurofinsus.com

Eurofins

BOURSE:ERF

Release Versions

Contacts

For more information, please contact:

Fredis Benitez
Global Marketing Analytics Manager, CPT
Mobile: +1 346-739-3816
E-mail: fredis.benitez@cpt.eurofinsus.com

More News From Eurofins

Eurofins MET Laboratories Opens New Safety, EMC, Wireless, and Renewable Energy Laboratory in the Boston Tech Corridor

BOSTON--(BUSINESS WIRE)--Eurofins MET Laboratories, part of the Eurofins Electrical & Electronics global network, announces the opening of its new state-of-the-art 60,000-square-foot testing laboratory in Littleton, Massachusetts – a prime location in the Boston innovation corridor. Positioned at the epicenter of New England's med-tech, wireless innovation, clean energy, and advanced electronics ecosystem, the capabilities of this laboratory further position Eurofins MET Laboratories as the...

Eurofins Scientific SE: Weekly Report on Share Repurchases from 26th January to 30th January 2026

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 26/01/2026 FR0014000MR3 5 000 70.7336 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 27/01/2026 FR0014000MR3 5 000 70.9680 XPAR EUROFINS SCIENTIFIC 529900JEHFM47...

Eurofins Delivers FY 2025 Objectives with a 24% EPS Growth, Accelerating Organic Revenue Growth, Margin Expansion, and Higher Free Cash Flow and Confirms Its 2027 Objectives

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF) pre-publishes below its preliminary unaudited consolidated financial results for the year ending 31 December 2025, as described in the first paragraphA of the Business Review section of this press release. Financial highlights in FY 2025 Basic EPS8 grew 24% to €2.31 in 2025 vs €1.87 in 2024, driven by a strong operating performance and starting to reap the benefits from Eurofins five-year investment programme in its hub and spok...
Back to Newsroom